Interferon for preventing and treating hepatocellular carcinoma associated with the hepatitis B and C viruses
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 35 (5) , 297-305
- https://doi.org/10.1016/s1590-8658(03)00071-9
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Influence of Previous Interferon Therapy on Recurrence after Resection of Hepatitis C Virus‐related Hepatocellular CarcinomaJapanese Journal of Cancer Research, 2001
- Development of Hepatocellular Carcinoma in a Patient With Chronic Hepatitis C After 6 Years of a Sustained and Complete Response to IFN-αJournal of Clinical Gastroenterology, 1999
- C ASE R EPORT: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis CJournal of Gastroenterology and Hepatology, 1999
- Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patientsJournal of Hepatology, 1999
- Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type CJournal of Hepatology, 1997
- Incidence of Hepatocellular Carcinoma after Interferon Therapy in Patients with Chronic Hepatitis C.The Tohoku Journal of Experimental Medicine, 1997
- Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5)Journal of Hepatology, 1996
- Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosisJournal of Hepatology, 1996
- Specific uptake of asialofetuin-tacked liposomes encapsulating interferon-γ by human hepatoma cells and its inhibitory effect on hepatitis B virus replicationBiochemical and Biophysical Research Communications, 1991
- Human lymphoblastoid interferonJournal of Hepatology, 1986